Christopher Bradburne

Christopher Bradburne

Auto-generated profile, based on publicly available information

Christopher Bradburne

Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in The Planetary Science Journal
Verified
Journal Article
Open access
PDF file
SMShannon MacKenzie
Shannon MacKenzie
MNMarc Neveu
Marc Neveu
ADAlfonso Davila
Alfonso Davila
JLJonathan I. Lunine
Jonathan I. Lunine
KCKathleen L. Craft
Kathleen L. Craft
LSLinda J. Spilker
Linda J. Spilker
Enceladus’s long-lived plume of ice grains and water vapor makes accessing oceanic material readily achievable from orbit (around Saturn or Enceladus) and from the moon’s surface. In preparation for the National Academies of Sciences, Engineering and Medicine 2023–2032 Planetary Science and Astrobiology Decadal Survey, we investigated four architectures capable of collecting and analyzing plume material from orbit and/or on the surface to address the most pressing questions at Enceladus: Is the subsurface ocean inhabited? Why, or why not? Trades specific to these four architectures were studied to allow an evaluation of the science return with respect to investment. The team found that Orbilander, a mission concept that would first orbit and then land on Enceladus, represented the best balance. Orbilander was thus studied at a higher fidelity, including a more detailed science operations plan during both orbital and landed phases, landing site characterization and selection analyses, and landing procedures. The Orbilander mission concept demonstrates that scientifically compelling but resource-conscious Flagship-class missions can be executed in the next decade to search for life at Enceladus.

29 January 2021 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
RPRobert A Player
Robert A Player
EFEllen R Forsyth
Ellen R Forsyth
KVKathleen J Verratti
Kathleen J Verratti
DMDavid W Mohr
David W Mohr
Alan ScottAlan Scott
Alan Scott
CBChristopher E Bradburne
Christopher E Bradburne
Reference genome fidelity is critically important for genome wide association studies, yet most vary widely from the study population. A typical whole genome sequencing approach implies short-read technologies resulting in fragmented assemblies with regions of ambiguity. Further information is lost by economic necessity when genotyping populations, as lower resolution technologies such as genotyping arrays are commonly used. Here, we present a phased reference genome for Canis lupus familiaris using high molecular weight DNA-sequencing technologies. We tested wet laboratory and bioinformatic approaches to demonstrate a minimum workflow to generate the 2.4 gigabase genome for a Labrador Retriever. The de novo assembly required eight Oxford Nanopore R9.4 flowcells (∼23X depth) and running a 10X Genomics library on the equivalent of one lane of an Illumina NovaSeq S1 flowcell (∼88X depth), bringing the cost of generating a nearly complete reference genome to less than $10K (USD). Mapping of short-read data from 10 Labrador Retrievers against this reference resulted in 1% more aligned reads versus the current reference (CanFam3.1, P < 0.001), and a 15% reduction of variant calls, increasing the chance of identifying true, low-effect size variants in a genome-wide association studies. We believe that by incorporating the cost to produce a full genome assembly into any large-scale genotyping project, an investigator can improve study power, decrease costs, and optimize the overall scientific value of their study.

1 November 2017 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
PDF file
CBChristopher Bradburne
Christopher Bradburne
JLJohn A. Lewis
John A. Lewis
Recent efforts in precision medicine present unique opportunities for military environmental and occupational health. Risk assessments can be refined by individualized risk factors such as genomics, and health status can be monitored and informed using mobile health (mHealth) devices. The military currently monitors exposures with service-wide databases and has one of the world's largest biobanks of serum samples available for health surveillance. New approaches are being developed for risk assessment, novel exposure-based biomarkers, and mobile applications to combine the facile collection of exposure data with tracking and planning utility. Planning by military leaders and coordination with national efforts puts the Department of Defense (DoD) in a unique position to benefit both Service Members and the nation, as reviewed in a symposium cosponsored by the DoD and the Johns Hopkins University-Applied Physics Laboratory (October 27 to 28, 2015).

5 September 2022 in Astrobiology
Verified
Journal Article
Open access
TVTessa Van Volkenburg
Tessa Van Volkenburg
JBJennifer Skerritt Benzing
Jennifer Skerritt Benzing
KCKathleen L. Craft
Kathleen L. Craft
KOKorine Ohiri
Korine Ohiri
AKAshley Kilhefner
Ashley Kilhefner
CBChristopher Bradburne
Christopher Bradburne
Increasing interest in the detection of biogenic signatures, such as amino acids, on icy moons and bodies within our solar system has led to the development of compact in situ instruments. Given the expected dilute biosignatures and high salinities of these extreme environments, purification of icy samples before analysis enables increased detection sensitivity. Herein, we outline a novel compact cation exchange method to desalinate proteinogenic amino acids in solution, independent of the type and concentration of salts in the sample. Using a modular microfluidic device, initial experiments explored operational limits of binding capacity with phenylalanine and three model cations, Na + , Mg 2+ , and Ca 2+ . Phenylalanine recovery (94–17%) with reduced conductivity (30–200 times) was seen at high salt-to-amino-acid ratios between 25:1 and 500:1. Later experiments tested competition between mixtures of 17 amino acids and other chemistries present in a terrestrial ocean sample. Recoveries ranged from 11% to 85% depending on side chain chemistry and cation competition, with concentration shown for select high affinity amino acids. This work outlines a nondestructive amino acid purification device capable of coupling to multiple downstream analytical techniques for improved characterization of icy samples at remote ocean worlds.

27 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
RPRobert A. Player
Robert A. Player
EFEllen R. Forsyth
Ellen R. Forsyth
KVKathleen J. Verratti
Kathleen J. Verratti
DMDavid W. Mohr
David W. Mohr
ASAlan F. Scott
Alan F. Scott
CBChristopher E. Bradburne
Christopher E. Bradburne
Reference genome fidelity is critically important for genome wide association studies (GWAS), yet many are incomplete or too dissimilar from the study population. A typical whole genome sequencing approach implies short-read technologies resulting in fragmented assemblies with regions of ambiguity low complexity. Further information is lost by economic necessity when genotyping populations, as lower resolution technologies such as genotyping arrays are commonly utilized. Here we present a phased reference genome for Canis lupus familiaris utilizing high molecular weight sequencing technologies. We tested wet lab and bioinformatic approaches to demonstrate a minimum workflow to generate the 2.4 gigabase genome for a Labrador Retriever. The resulting de novo assembly required eight Oxford Nanopore R9.4 flowcells (~23X depth) and running a 10X Genomics library on the equivalent of one lane of an Illumina NovaSeq S1 flowcell (~88X depth), bringing the cost of generating a nearly complete reference genome to less than $10K. Mapping of publicly available short-read data from ten Labrador Retrievers against this breed-specific reference resulted in an average of approximately 1% more aligned reads compared to mapping against the current gold standard reference (CanFam3.1, p<0.001), indicating a more complete breed-specific reference. An average 15% reduction of variant calls was observed from the same mapped data, which increases the chance of identifying low effect size variants in a GWAS. We believe that by incorporating the cost to produce a full genome assembly into any large-scale canine genotyping study, an investigator can make an informed cost/benefit analysis regarding genotyping technology.

18 November 2016 in Expert Review of Precision Medicine and Drug Development
Verified
Journal Article
Closed access
CBChristopher Bradburne
Christopher Bradburne
AHAda Hamosh
Ada Hamosh
National momentum for precision medicine is reaching its stride. Since the draft sequence of the human genome in 2001, millions of humans have been genotyped, a million people have undergone exome ...